Subclinical iron deficiency is a strong predictor of bacterial vaginosis in early pregnancy

Hans Verstraelen, Joris Delanghe, Kristien Roelens, Stijn Blot, Geert Claeys, Marleen Temmerman, Hans Verstraelen, Joris Delanghe, Kristien Roelens, Stijn Blot, Geert Claeys, Marleen Temmerman

Abstract

Background: Bacterial vaginosis (BV) is the single most common vaginal infection in women of childbearing age and associated with a sizeable infectious disease burden among both non-pregnant and pregnant women, including a significantly elevated risk of adverse pregnancy outcome. Overall, little progress has been made in identifying causal factors involved in BV acquisition and persistence. We sought to evaluate maternal iron status in early pregnancy as a putative risk factor for BV, considering that micronutrients, and iron deficiency in particular, affect the host response against bacterial colonization, even in the setting of mild micronutrient deficiencies.

Methods: In a nested case-control study, we compared maternal iron status at entry to prenatal care (mean gestational age 9.2 +/- 2.6 weeks) between eighty women with healthy vaginal microflora and eighteen women with vaginosis-like microflora. Vaginal microflora status was assessed by assigning a modified Nugent score to a Gram-stained vaginal smear. Maternal iron status was assayed by an array of conventional erythrocyte and serum indicators for iron status assessment, but also by more sensitive and more specific indicators of iron deficiency, including soluble transferrin receptors (sTfR) as an accurate measure of cellular and tissue iron deficiency and the iron deficiency log10[sTfR/ferritin] index as the presently most accurate measure of body storage iron available.

Results: We found no statistically significant correlation between vaginal microflora status and routinely assessed iron parameters. In contrast, a highly significant difference between the healthy and vaginosis-like microflora groups of women was shown in mean values of sTfR concentrations (1.15 +/- 0.30 mg/L versus 1.37 +/- 0.38 mg/L, p = 0.008) and in mean iron deficiency log10[sTfR/ferritin] index values (1.57 +/- 0.30 versus 1.08 +/- 0.56, p = 0.003), indicating a strong association between iron deficiency and vaginosis-like microflora. An sTfR concentration > 1.45 mg/L was associated with a 3-fold increased risk (95%CI: 1.4-6.7) of vaginosis-like microflora and after controlling for maternal age, gestational length, body mass, parity, and smoking habits with an adjusted odds ratio of 4.5 (95%CI: 1.4-14.2).

Conclusion: We conclude that subclinical iron deficiency, presumably resulting from inadequate preconceptional iron supplies, is strongly and independently associated with vaginosis-like microflora during early pregnancy.

Figures

Figure 1
Figure 1
Distribution of sTfR concentrations according to vaginal microflora status. Box-and-whisker plots of the sTfR distributions according to vaginal microflora status during early pregnancy. The thick line represents the median sTfR value, the horizontal box lines the 25th percentile and 75th percentile, and the outer short horizontal lines the boundaries of the sTfR range. Healthy vaginal flora is defined as grade I or lactobacilli-dominated microflora on Gram stain (corresponding to a Nugent score 0 – 3) and disturbed vaginal flora is defined as grade II and grade III flora, this is mixed or gram-negative rods-dominated microflora on Gram stain (corresponding to a Nugent score ≥4).

References

    1. Hillier SL, Krohn MA, Rabe LK, Klebanoff SJ, Eschenbach DA. The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis. 1993. pp. 273–81.
    1. Antonio MA, Hawes SE, Hillier SL. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis. 1999;180:1950–6. doi: 10.1086/315109.
    1. Verhelst R, Verstraelen H, Claeys G, Verschraegen G, Delanghe J, Van Simaey L, De Ganck C, Temmerman M, Vaneechoutte M. Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol. 2004;4:16. doi: 10.1186/1471-2180-4-16.
    1. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297–301.
    1. Hillier SL, Krohn MA, Klebanoff SJ, Eschenbach DA. The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol. 1992;79:369–73.
    1. Delaney ML, Onderdonk AB. Nugent score related to vaginal culture in pregnant women. Obstet Gynecol. 2001;98:79–84. doi: 10.1016/S0029-7844(01)01402-8.
    1. Ferris MJ, Masztal A, Aldridge KE, Fortenberry JD, Fidel PL, Jr, Martin DH. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis. 2004;4:5. doi: 10.1186/1471-2334-4-5.
    1. Burton JP, Devillard E, Cadieux PA, Hammond JA, Reid G. Detection of Atopobium vaginae in postmenopausal women by cultivation-independent methods warrants further investigation. J Clin Microbiol. 2004;42:829–31. doi: 10.1128/JCM.42.4.1829-1831.2004.
    1. Verstraelen H, Verhelst R, Claeys G, Temmerman M, Vaneechoutte M. Culture-independent analysis of vaginal microflora: The unrecognized association of Atopobium vaginae with bacterial vaginosis. Am J Obstet Gynecol. 2004;191:1130–2. doi: 10.1016/j.ajog.2004.04.013.
    1. Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA. 2004;291:1368–79. doi: 10.1001/jama.291.11.1368.
    1. Sobel JD. Bacterial vaginosis. Annu Rev Med. 2000;51:349–56. doi: 10.1146/annurev.med.51.1.349.
    1. Leitich H, Bodner-Adler B, Brunbauer M, Kaider A, Egarter C, Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 2003;189:139–47. doi: 10.1067/mob.2003.339.
    1. Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis. 2003;36:663–8. doi: 10.1086/367658.
    1. Taha TE, Gray RH, Kumwenda NI, Hoover DR, Mtimavalye LA, Liomba GN, Chiphangwi JD, Dallabetta GA, Miotti PG. HIV infection and disturbances of vaginal flora during pregnancy. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:52–59.
    1. Royce RA, Thorp J, Granados JL, Savitz DA. Bacterial vaginosis associated with HIV infection in pregnant women from North Carolina. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:382–6.
    1. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, Wabwire-Mangen F, Serwadda D, Li C, Kiwanuka N, Hillier SL, Rabe L, Gaydos CA, Quinn TC, Konde-Lule J. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet. 1997;350:546–550. doi: 10.1016/S0140-6736(97)01063-5.
    1. Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP, Liomba GN, Broadhead RL, Chiphangwi JD, Miotti PG. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 1998;12:1699–1706. doi: 10.1097/00002030-199813000-00019.
    1. Martin H, Nyange PM, Richardson BA, Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya-Achola JO, Bwayo J, Kreiss J. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis. 1999;180:1863–8. doi: 10.1086/315127.
    1. Hashemi FB, Ghassemi M, Roebuck KA, Spear GT. Activation of human immunodeficiency type I expression by Garnerella vaginalis. J Infect Dis. 1999;179:924. doi: 10.1086/314674.
    1. Morris M, Nicoll A, Simms I, Wilson J, Catchpole M. Bacterial vaginosis: a public health review. BJOG. 2001;108:439–50. doi: 10.1016/S0306-5456(00)00124-8.
    1. Hay PE. Recurrent bacterial vaginosis. Dermatol Clin. 1998;16:769–73.
    1. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect. 2004;80:8–11. doi: 10.1136/sti.2002.002733.
    1. Genc MR, Onderdonk A, Witkin SS. Innate Immune System Gene Polymorphisms in Women with Vulvovaginal Infections. Curr Infect Dis Rep. 2004;6:462–468.
    1. Genc MR, Vardhana S, Delaney ML, Onderdonk A, Tuomala R, Norwitz E, Witkin SS, MAP Study Group Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol. 2004;116:152–6. doi: 10.1016/j.ejogrb.2004.02.010.
    1. Simhan H, Caritis S, Hillier S, Krohn M. Cervical anti-inflammatory cytokine concentrations are decreased among pregnant women with bacterial vaginosis [abstract] Am J Obstet Gynecol. 2004:11. doi: 10.1016/j.ajog.2004.09.060.
    1. Bendich A. Micronutrients in women's health and immune function. Nutrition. 2001;17:858–67. doi: 10.1016/S0899-9007(01)00649-9.
    1. Bhaskaram P. Immunobiology of mild micronutrient deficiencies. Br J Nutr. 2001. pp. 75–80.
    1. Scholl TO, Reilly T. Anemia, iron and pregnancy outcome. J Nutr. 2000. pp. 443–7.
    1. Allen LH. Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr. 2000. pp. 1280–4.
    1. Ison CA, Hay PE. Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm Infect. 2002;78:413–5. doi: 10.1136/sti.78.6.413.
    1. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta. 2003;329:9–22. doi: 10.1016/S0009-8981(03)00005-6.
    1. Skikne BS, Flowers CH, Cook JD. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood. 1990;75:1870–6.
    1. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood. 2003;101:3359–64. doi: 10.1182/blood-2002-10-3071.
    1. Akesson A, Bjellerup P, Berglund M, Bremme K, Vahter M. Soluble transferrin receptor: longitudinal assessment from pregnancy to postlactation. Obstet Gynecol. 2002;99:260–6. doi: 10.1016/S0029-7844(01)01684-2.
    1. Akesson A, Bjellerup P, Berglund M, Bremme K, Vahter M. Serum transferrin receptor: a specific marker of iron deficiency in pregnancy. Am J Clin Nutr. 1998;68:1241–6.
    1. Beguin Y, Lipscei G, Thoumsin H, Fillet G. Blunted erythropoietin production and decreased erythropoiesis in early pregnancy. Blood. 1991;78:89–93.
    1. Choi JW, Im MW, Pai SH. Serum transferrin receptor concentrations during normal pregnancy. Clin Chem. 2000;46:725–7.
    1. Bothwell TH. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr. 2000;72:257–264.
    1. Yip R. Significance of an abnormally low or high hemoglobin concentration during pregnancy: special consideration of iron nutrition. Am J Clin Nutr. 2000. pp. 272–9.
    1. Casanueva E, Viteri FE. Iron and oxidative stress in pregnancy. J Nutr. 2003. pp. 1700–8.
    1. Bernstein IM, Ziegler W, Badger GJ. Plasma volume expansion in early pregnancy. Obstet Gynecol. 2001;97:669–72. doi: 10.1016/S0029-7844(00)01222-9.
    1. Vora M, Gruslin A. Erythropoietin in obstetrics. Obstet Gynecol Surv. 1998;53:500–8. doi: 10.1097/00006254-199808000-00023.
    1. O'Brien KO, Zavaleta N, Abrams SA, Caulfield LE. Maternal iron status influences iron transfer to the fetus during the third trimester of pregnancy. Am J Clin Nutr. 2003;77:924–30.
    1. Radtke H, Tegtmeier J, Rocker L, Salama A, Kiesewetter H. Daily doses of 20 mg of elemental iron compensate for iron loss in regular blood donors: a randomized, double-blind, placebo-controlled study. Transfusion. 2004;44:1427–32. doi: 10.1111/j.1537-2995.2004.04074.x.
    1. Bloomfield FH, Oliver MH, Hawkins P, Campbell M, Phillips DJ, Gluckman PD, Challis JR, Harding JE. A periconceptional nutritional origin for noninfectious preterm birth. Science. 2003;300:606. doi: 10.1126/science.1080803.

Source: PubMed

3
Abonnieren